Delwedd Flaen

Antibacterial Therapy in Adults with COVID-19

Since the emergence of the Coronavirus-19 infectious disease (COVID-19) pandemic, a rising number of reports have underlined the risk of increasing antimicrobial resistance due to antibiotic overuse in COVID-19 patients. In addition, many physicians and pharmacists involved in antimicrobial stewards...

Disgrifiad llawn

Wedi'i Gadw mewn:
Fformat: Online
Iaith:Saesneg
Cyhoeddwyd: MDPI - Multidisciplinary Digital Publishing Institute 2023
Pynciau:
COVID-19
antimicrobial use
multicentre
point-prevalence study
Influenza
co-infection
secondary infections
aspergillosis
ivermectin
randomized-controlled trial
prevention
treatment
SARS-CoV-2
antiviral
antibiotic
azithromycin
remdesivir
macrolides
virus
coronavirus
immunolides
antivirus
pandemics
procalcitonin
SARS virus
community-acquired infections
emergency service
hospital
pneumonia
viral
community-acquired pneumonia
Mid-regional Pro-adrenomedullin
ARDS
biomarker
prognosis
superinfection
bacterial co-infection
bacterial superinfection
antibiotic stewardship
AMR
antibiotics
cephalosporin
secondary infection
variant of concern
interleukin-6 receptor antagonist
early administration
mortality rates
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine
Mynediad Ar-lein:ONIX_20230405_9783036568133_80
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg: Antibacterial Therapy in Adults with COVID-19

Eitemau Tebyg